Current observations in the literature suggest that vitamin E may be a suitable candidate for
the adjuvant treatment of cancer. Even though historically most research focused on α …

Cancer prevention remains the ideal strategy for reducing the burden of cancer on society.
Progress in cancer prevention has been accelerated as prevention clinical trials are …

Prostate cancer is the most common invasive malignancy and the second leading cause of
cancer-related deaths among US males, with a similar trend in many Western countries. One …

Prostate cancer (CaP) is the second leading cause of cancer-related deaths among US
males with a similar trend in many Western countries. CaP is an ideal candidate disease for …

Epidemiological studies have consistently associated high intakes of lycopene or vitamin E
with a reduced prostate cancer risk. Both compounds were tested in the MatLyLu Dunning …

The IGF axis is critical for the regulation of apoptosis in many human cancer cell lines.
Recently, potent anti-tumorigenic effects of pomegranate juice and extracts have been …

Valproic acid (VPA) is an established drug in the long-term therapy of seizure disorders.
Recently, VPA has been associated with anticancer activity, an effect thought to be mediated …

Vitamin E isoforms have been extensively studied for their anticancer properties. Novel drug
delivery systems (DDS) that include liposomes, nanoparticles, and micelles are actively …

Prostate cancer is one of the most frequent cancer types in Western societies and
predominately occurs in the elderly male. The strong age-related increase of prostate cancer …

Objective: The transhydroxystilbene resveratrol is found at high levels in red wine and
grapes, and red wine consumption may be inversely associated with prostate cancer risk. To …